Form 8-K - Current report:
SEC Accession No. 0000950170-24-127767
Filing Date
2024-11-18
Accepted
2024-11-18 07:00:08
Documents
11
Period of Report
2024-11-18
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant

Document Format Files

Seq Description Document Type Size
1 8-K hcwb-20241118.htm   iXBRL 8-K 41439
  Complete submission text file 0000950170-24-127767.txt   159565

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT hcwb-20241118.xsd EX-101.SCH 25994
13 EXTRACTED XBRL INSTANCE DOCUMENT hcwb-20241118_htm.xml XML 4928
Mailing Address 2929 N COMMERCE PKWY MIRAMAR FL 33025
Business Address 2929 N COMMERCE PKWY MIRAMAR FL 33025 954-842-2024
HCW Biologics Inc. (Filer) CIK: 0001828673 (see all company filings)

EIN.: 825024477 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40591 | Film No.: 241469735
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)